(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NO ONE MISSED

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NO ONE MISSED

ST13

US500000098267946

Class

35

Filing

98267946

Registration

7675531

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

02/04/2025

Trademark type

Combined

Nice classes

35

Filing date

11/13/2023

Registration date

02/04/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/04/2025

Last transaction

02/04/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

04/14/2021

First use in commerce

04/14/2021

Drawing code

3

Owner type

99

Owner location

Chicago, IL

Examiner

NISHIGAYA, CHRISTINE EIKO

Law office

O50

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the words "NO ONE" over the word "MISSED" in bold type font. Above the wording "NO ONE" are corner elements at the top left and top right. Below the wording "MISSED" is a corner element on the bottom right, and an arrow head at the bottom left pointing at the capital letter "M" in the word "MISSED". The wording "NO ONE MISSED" is in Poppins font.

Holders and representatives

Holders

L. F. (pessoa física)

Representatives

LUNGevity Foundation

Technical classification

Nice Classes

Class 35

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Promoting public awareness of comprehensive biomarker testing as a critical part of every nonsmall cell lung cancer (NSCLC) and other cancer diagnosis and empower patients to discuss comprehensive biomarker testing healthcare team.

Publications

History of USPTO decisions and trademark events.

30 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/04/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

02/04/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/17/2024

PUBO

PUBLISHED FOR OPPOSITION

12/17/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/11/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/16/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/09/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/09/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/09/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/27/2024

GNRT

NON-FINAL ACTION E-MAILED

09/27/2024

CNRT

NON-FINAL ACTION WRITTEN

09/27/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/13/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/13/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/13/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/09/2024

GNRT

NON-FINAL ACTION E-MAILED

09/09/2024

CNRT

NON-FINAL ACTION WRITTEN

09/09/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/21/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/21/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

08/21/2024

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

08/21/2024

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

08/21/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

06/21/2024

GNRT

NON-FINAL ACTION E-MAILED

06/21/2024

CNRT

NON-FINAL ACTION WRITTEN

06/21/2024

DOCK

ASSIGNED TO EXAMINER

06/16/2024

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

01/31/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/31/2024

NWAP

NEW APPLICATION ENTERED

11/13/2023

Continuous trademark protection

Get notified about every new filing that threatens NO ONE MISSED or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.